IN2014CN02870A - - Google Patents

Info

Publication number
IN2014CN02870A
IN2014CN02870A IN2870CHN2014A IN2014CN02870A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A IN 2870CHN2014 A IN2870CHN2014 A IN 2870CHN2014A IN 2014CN02870 A IN2014CN02870 A IN 2014CN02870A
Authority
IN
India
Prior art keywords
proteins
relates
kits used
diagnosis
therapeutic
Prior art date
Application number
Inventor
Oleg Melnyk
Laurent Raibaut
Vincent Aucagne
Agnès Delmas
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Publication of IN2014CN02870A publication Critical patent/IN2014CN02870A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/026—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution by fragment condensation in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/045—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers using devices to improve synthesis, e.g. reactors, special vessels
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/34—Introducing sulfur atoms or sulfur-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The invention relates to a method for assembling proteins from peptide fragments. Said method enables the production of proteins in a simple reliable manner that can be applied on an industrial scale. This method makes it possible to produce proteins with therapeutic or diagnostic value. The invention also relates to kits used for implementing said method for synthesizing proteins and to kits used in testing and/or diagnosis.
IN2870CHN2014 2011-10-17 2012-10-16 IN2014CN02870A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1159348A FR2981352B1 (en) 2011-10-17 2011-10-17 PROCESS FOR PROTEIN SYNTHESIS
PCT/EP2012/070454 WO2013057084A1 (en) 2011-10-17 2012-10-16 Method for synthesizing proteins

Publications (1)

Publication Number Publication Date
IN2014CN02870A true IN2014CN02870A (en) 2015-07-03

Family

ID=47022687

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2870CHN2014 IN2014CN02870A (en) 2011-10-17 2012-10-16

Country Status (10)

Country Link
US (1) US9206224B2 (en)
EP (1) EP2768842B1 (en)
JP (1) JP6321542B2 (en)
CN (1) CN103998455B (en)
CA (1) CA2852833A1 (en)
ES (1) ES2702786T3 (en)
FR (1) FR2981352B1 (en)
IN (1) IN2014CN02870A (en)
SG (1) SG11201401540WA (en)
WO (1) WO2013057084A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971509B1 (en) * 2011-02-16 2013-02-22 Centre Nat Rech Scient PROCESS FOR PREPARING PEPTIDES BY ASSEMBLING MULTIPLE PEPTIDE FRAGMENTS
EA201690205A1 (en) * 2013-07-11 2016-12-30 Новартис Аг SITE-SPECIFIC CHEMICAL-ENMENTATIVE MODIFICATIONS OF PROTEINS
NL2027769B1 (en) 2021-03-18 2022-09-29 Univ Delft Tech C-terminal peptide modification

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU711451B2 (en) 1995-05-04 1999-10-14 Scripps Research Institute, The Synthesis of proteins by native chemical ligation
CA2273071C (en) 1996-12-24 2008-07-29 The Scripps Research Institute Method for ligating oligopeptides
JP2002505672A (en) * 1997-06-13 2002-02-19 グライフォン サイエンシズ Solid-phase natural chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution
ATE329925T1 (en) 2000-03-16 2006-07-15 Univ California CHEMOSELEVANT ATTACHMENT USING A PHOSPHINE
WO2001087920A2 (en) 2000-05-12 2001-11-22 Wisconsin Alumni Research Foundation Ligation method and reagents to form an amide bond
EP1456225A2 (en) 2001-11-14 2004-09-15 Geneprot, Inc. Extended native chemical ligation of three or more peptide fragments
CA2584906A1 (en) * 2004-10-26 2006-05-04 Lonza Ag S-alkyl-sulphenyl protection groups in solid-phase synthesis
BRPI0607935A2 (en) * 2005-02-11 2009-10-20 Merck Patent Gmbh solid phase oligosaccharide labeling: a technique for handling immobilized carbohydrates
US7667076B2 (en) 2005-09-14 2010-02-23 Regents Of The University Of California Amide forming chemical ligation
FR2952058B1 (en) * 2009-10-29 2013-10-04 Centre Nat Rech Scient PROCESS FOR NATIVE LIGATION OF POLYPEPTIDES
CA2780142C (en) 2009-11-16 2018-07-17 Centre National De La Recherche Scientifique - Cnrs Compounds and methods for purifying peptides produced by solid phase peptide synthesis

Also Published As

Publication number Publication date
WO2013057084A1 (en) 2013-04-25
JP6321542B2 (en) 2018-05-09
SG11201401540WA (en) 2014-06-27
CN103998455A (en) 2014-08-20
EP2768842A1 (en) 2014-08-27
FR2981352B1 (en) 2015-07-03
US20140256879A1 (en) 2014-09-11
CN103998455B (en) 2018-05-29
EP2768842B1 (en) 2018-07-25
JP2014532075A (en) 2014-12-04
FR2981352A1 (en) 2013-04-19
ES2702786T3 (en) 2019-03-05
CA2852833A1 (en) 2013-04-25
US9206224B2 (en) 2015-12-08

Similar Documents

Publication Publication Date Title
CY1120390T1 (en) COMPOSITION AND METHOD FOR DIAGNOSIS AND TREATMENT OF DISEASES RELATING TO NURSES
EP4327885A3 (en) Antibody constructs for msln and cd3
EP4282484A3 (en) Bispecific antibodies against cd3epsilon and bcma for use in treatment of diseases
NZ760022A (en) Antibody-based therapy of transthyretin (ttr) amyloidosis and human-derived antibodies therefor
MX2018009304A (en) Diagnostic and prognostic methods for cardiovascular diseases and events.
WO2014124334A3 (en) Transthyretin antibodies and uses thereof
NZ718280A (en) Antibodies against claudin 18.2 useful in cancer diagnosis
MX337535B (en) Antibody, kit and method for determining amyloid peptides.
EA201690213A1 (en) COMPOSITIONS AND METHOD FOR TREATMENT OF CONNECTED STATES
PH12017500489A1 (en) Human-derived anti-dipeptide repeats (dprs) antibody
EA201790438A1 (en) ANTIGEN-BINDING PROTEINS THAT CONNECT WITH CXCR5
MX358474B (en) Specific salivary biomarkers for risk detection, early diagnosis, prognosis and monitoring of alzheimer's and parkinson's diseases.
BR112013024213A2 (en) medical instrument and method of manufacture
MX2016000393A (en) Lysine-specific chemoenzymatic protein modifications using microbial transglutaminase.
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
WO2014091490A3 (en) Diagnosis of autoimmune diseases using a specific antibody profile
NZ716643A (en) Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event
TR201900550T4 (en) Antibody that binds a linear epitope of human p53 and its diagnostic applications.
WO2015001013A3 (en) Human anti-ifn-alpha antibodies
WO2013167727A3 (en) Method for determining arthritis relapse risk
EP3696190A3 (en) Methods
IN2014CN02870A (en)
EA029703B9 (en) Novel allergen from ragweed pollen and uses thereof
EP3112867A4 (en) Qualitative predictive method for differential diagnosis of pneumococcic, meningococcic and viral menigitis, differential meningitis diagnostic method and kit
MX371426B (en) Method for predicting the onset of extrapyramidal symptoms (eps) induced by an antipsychotic-based treatment.